The global spine biologics market is predicted to exceed more than $2.5 billion by 2022 with a growth rate of 4.4 percent, Finance Wire reports.
Biologics
The surgery of spines has begun in the late 1800s. It was not systematic until around 1916 when the neurosurgeon Dr. Charles Elsberg published a book mentioning how to perform surgical procedures on the spine and spinal cord for various…